Clinical Study of IM96 CAR-T Cell Therapy in Patients With Advanced Colorectal Cancer

Clinical trial NCT06718738 · RECRUITING

Trial details

NCT number: NCT06718738
Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer (CRC)

Start date: 2024-12-15
Primary completion: 2025-08-15
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.